Torsten Herbertz - Concepedia

Author

Torsten Herbertz

Rutgers, The State University of New Jersey

Also Known As

T. HERBERTZ, T. Herbertz, Torsten Herbertz

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Rutgers, The State University of New Jersey Forma Therapeutics (United States)Pearl River Community College Cubist Pharmaceuticals (United States)TetraLogic Pharmaceuticals (United States)

About

Torsten Herbertz is an author at Rutgers, The State University of New Jersey specializing in natural sciences, biochemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	12	12	667
2	Medicine	8	8	829
3	Biochemistry	8	8	183
4	Engineering	6	6	116
5	Biomolecular Engineering	4	4	499

Torsten Herbertz

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery Arup K. Ghose, Torsten Herbertz, Robert L. Hudkins, ACS Chemical Neuroscience Cns Drug DiscoveryPharmaceutical ResearchDrug TargetHit IdentificationLead Identification	2011	432
VP1 Sequencing of All Human Rhinovirus Serotypes:Insights into Genus Phylogeny and Susceptibility to AntiviralCapsid-BindingCompounds Rebecca M. Ledford, Nitesh R. Patel, Tina M. Demenczuk, Journal of Virology Virus SusceptibilityViral EvolutionMolecular VirologyGeneticsPathogenesis	2004	209
Identification of 1-(3-(6,7-Dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea Hydrochloride (CEP-32496), a Highly Potent and Orally Efficacious Inhibitor of V-RAF Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) V600E Martin W. Rowbottom, Raffaella Faraoni, Qi Chao, Journal of Medicinal Chemistry Orally Efficacious InhibitorChemoprevention StrategyImmunologySeveral BrafAntiviral Drug	2011	58
The discovery and structure–activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase Matthew G. LaPorte, Tandy L. Draper, Lori E. Miller, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryViral Polymerase StructureMedicineNatural Sciences	2010	34
Electron Transfer Photochemistry of Chrysanthemol: An Intramolecular S<sub>N</sub>2‘ Reaction of a Vinylcyclopropane Radical Cation Torsten Herbertz, Heinz D. Roth Journal of the American Chemical Society	1996	33
FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer Maureen Caligiuri, Grace L. Williams, Jennifer Castro, Targeted Oncology	2023	29
Elucidation of the Bioactive Conformation of the <i>N</i>-Substituted <i>trans</i>-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine Class of μ-Opioid Receptor Antagonists Bertrand Le Bourdonnec, Mathieu Michaut, Hai‐Fen Ye, Journal of Medicinal Chemistry Bioactive ConformationMedicinal ChemistryConstrained Analogue 9BiochemistryMedicine	2006	28
The Discovery of Pyrano[3,4‐<i>b</i>]indole‐Based Allosteric Inhibitors of HCV NS5B Polymerase with In Vivo Activity Matthew G. LaPorte, Randy W. Jackson, Tandy L. Draper, ChemMedChem ImmunologyAllosteric InhibitorsAntiviral DrugMedicinal ChemistryViral Hepatitis	2008	28
Solid/Solution‐Phase Annulation Reagents: Single‐Step Synthesis of Cyclic Amine Derivatives Roland E. Dolle, Calum Macleod, Blanca Martínez‐Teipel, Angewandte Chemie International Edition Derivative (Chemistry)Diversity Oriented SynthesisDerivativesEngineeringHeterocyclic	2005	26
The discovery and structure–activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase Randy W. Jackson, Matthew G. LaPorte, Torsten Herbertz, Bioorganic & Medicinal Chemistry Letters Viral Polymerase StructureBiochemistryMedicineAntiviral Drug DevelopmentAntiviral Therapy	2011	23

Page 1